Have a personal or library account? Click to login
Oxidative stress and metabolic parameters in hypertensive patients with/without diabetes mellitus in cardiovascular risk evaluation Cover

Oxidative stress and metabolic parameters in hypertensive patients with/without diabetes mellitus in cardiovascular risk evaluation

Revista Romana de Medicina de Laborator
Volume 30 (2022): Issue 4 (October 2022)
By: Enikő Nemes-Nagy,  Erzsébet Fogarasi,  Mircea Dumitru Croitoru,  Zoltán Preg,  Sándor Pál,  Kinga-Ilona Nyulas,  Tünde Pál,  Robert Gabriel Tripon,  Mariana Cornelia Tilinca and  Márta Germán-Salló  
Open Access
|Oct 2022

References

  1. 1. Bernabé-Ortiz A, Carrillo-Larco RM, Gilman RH, Checkley W, Smeeth L, Miranda JJ, CRONICAS Cohort Study Group. Impact of urbanisation and altitude on the incidence of, and risk factors for, hypertension. Heart. 2017 Jun;103(11):827-3310.1136/heartjnl-2016-310347552998028115473
    Search in Google ScholarBack to article
  2. 2. Roumie CL, Hung AM, Russell GB, Basile J, Kreider KE, Nord J, et al. Blood pressure control and the association with diabetes mellitus incidence: results from SPRINT randomized trial. Hypertension. 2020 Feb;75(2):331-810.1161/HYPERTENSIONAHA.118.12572701514731865790
    Search in Google ScholarBack to article
  3. 3. Shaikh A. A practical approach to hypertension management in diabetes. Diabetes Ther. 2017 Oct;8(5):981-910.1007/s13300-017-0310-3563056428929319
    Search in Google ScholarBack to article
  4. 4. Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018 May;34(5):575-8410.1016/j.cjca.2017.12.005595355129459239
    Search in Google ScholarBack to article
  5. 5. Carey RM, Wright Jr JT, Taler SJ, Whelton PK. Guideline-driven management of hypertension: an evidence-based update. Circ Res. 2021 Apr;128(7):827-4610.1161/CIRCRESAHA.121.318083803480133793326
    Search in Google ScholarBack to article
  6. 6. Del Pinto R, Ferri C. Inflammation-accelerated senescence and the cardiovascular system: mechanisms and perspectives. Int J Mol Sci. 2018 Dec;19(12):370110.3390/ijms19123701632136730469478
    Search in Google ScholarBack to article
  7. 7. Mahajan N, Arora P, Sandhir R. Perturbed biochemical pathways and associated oxidative stress lead to vascular dysfunctions in diabetic retinopathy. Oxid Med Cell Longev. 2019 Mar;2019:1-1610.1155/2019/8458472643138030962865
    Search in Google ScholarBack to article
  8. 8. Tilinca MC, Barabas-Hajdu EC, Ferencz GT, Nemes-Nagy E. Involvement of inflammatory cytokines in obesity and its complications. R Rom Med Lab. 2018;26(3):359-7110.2478/rrlm-2018-0019
    Search in Google ScholarBack to article
  9. 9. Vona R, Gambardella L, Cittadini C, Straface E, Pietra-forte D. Biomarkers of oxidative stress in metabolic syndrome and associated diseases. Oxid Med Cell Longev. 2019 Oct;2019:1-1910.1155/2019/8267234652582331191805
    Search in Google ScholarBack to article
  10. 10. Prakash D. Target organ damage in newly detected hypertensive patients. J Family Med Prim Care. 2019 Jun;8(6):2042-4610.4103/jfmpc.jfmpc_231_19661823131334177
    Search in Google ScholarBack to article
  11. 11. Wali U, Hussain MM, Wali N, Nadeem A, Majeed F. Comparison of serum levels of Cystatin-C and traditional renal biomarkers for the early detection of pre-hypertensive nephropathy. J Pak Med Assoc. 2019 Mar 1;69(3):313-19
    Search in Google ScholarBack to article
  12. 12. Elsayed MS, El Badawy A, Omar R, Mohamed A. Serum cystatin C as an indicator for early detection of diabetic nephropathy in type 2 diabetes mellitus. Diabetes Metab Syndr Clin Res Rev. 2019 Jan;13(1):374-8110.1016/j.dsx.2018.08.01730641728
    Search in Google ScholarBack to article
  13. 13. Khalil H. Diabetes microvascular complications - A clinical update. Diabetes Metab Syndr Clin Res Rev. 2017;11:S133-910.1016/j.dsx.2016.12.02227993541
    Search in Google ScholarBack to article
  14. 14. Greaney JL, Saunders EF, Santhanam L, Alexander LM. Oxidative stress contributes to microvascular endothelial dysfunction in men and women with major depressive disorder. Circ Res. 2019;124(4):564-7410.1161/CIRCRESAHA.118.313764637580030582458
    Search in Google ScholarBack to article
  15. 15. Mirmiran P, Hosseini-Esfahani F, Esfandiar Z, Hossein-pour-Niazi S, Azizi F. Associations between dietary antioxidant intakes and cardiovascular disease. Sci Rep. 2022 Jan;12(1):1-1110.1038/s41598-022-05632-x879539935087166
    Search in Google ScholarBack to article
  16. 16. Ruiz-Castell M, Le Coroller G, Landrier JF, Kerkour D, Weber B, Fagherazzi G, et al. Micronutrients and Markers of Oxidative Stress and Inflammation Related to Cardiometabolic Health: Results from the EHESLUX Study. Nutrients. 2021 Jan;13(5):1-1310.3390/nu13010005782200933374992
    Search in Google ScholarBack to article
  17. 17. Gould RL, Pazdro R. Impact of supplementary amino acids, micronutrients, and overall diet on glutathione homeostasis. Nutrients. 2019 May;11(5):1051-5610.3390/nu11051056656616631083508
    Search in Google ScholarBack to article
  18. 18. Ho E, Galougahi KK, Liu CC, Bhindi R, Figtree GA. Biological markers of oxidative stress: applications to cardiovascular research and practice. Redox biology. 2013 Jan;1(1):483-9110.1016/j.redox.2013.07.006383006324251116
    Search in Google ScholarBack to article
  19. 19. Bigagli E, Lodovici M. Circulating oxidative stress biomarkers in clinical studies on type 2 diabetes and its complications. Oxid Med Cell Longev. 2019 May;2019:1-1710.1155/2019/5953685653585931214280
    Search in Google ScholarBack to article
  20. 20. Fogarasi E, Croitoru MD, Fülöp I, Nemes-Nagy E, Tripon RG, Simon-Szabo Z, et al. Malondialdehyde levels can be measured in serum and saliva by using a fast HPLC method with visible detection. R Rom Med Lab Vol. 2016;24(3):319-326
    Search in Google ScholarBack to article
  21. 21. Artha IM, Bhargah A, Dharmawan NK, Pande UW, Triyana KA, Mahariski PA, et al. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus. Vasc Health Risk Manag. 2019;15:149-15710.2147/VHRM.S209830656018331239693
    Search in Google ScholarBack to article
  22. 22. Yiğitbaşı T, Baskın Y, Akgöl E, Çalıbaşı Koçal G, Ellidokuz H. Association of ischemia-modified albumin with oxidative stress status and insulin resistance in obese patients. R Rom Med Lab. 2017. 25(3):255-6310.1515/rrlm-2017-0020
    Search in Google ScholarBack to article
  23. 23. Ceriello A, De Cosmo S, Rossi MC, Lucisano G, Genovese S, Pontremoli R, et al. Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes. Diabetes Obes Metab. 2017 Nov;19(11):1570-810.1111/dom.1297628432733
    Search in Google ScholarBack to article
  24. 24. Nam KW, Kwon HM, Jeong HY, Park JH, Kwon H, Jeong SM. High triglyceride/HDL cholesterol ratio is associated with silent brain infarcts in a healthy population. BMC neurology. 2019 Dec;19(1):1-810.1186/s12883-019-1373-8660443331266453
    Search in Google ScholarBack to article
  25. 25. Song Y, Choi JE, Kwon YJ, Chang HJ, Kim JO, Park DH, et al. Identification of susceptibility loci for cardiovascular disease in adults with hypertension, diabetes, and dyslipidemia. J Transl Med. 2021 Dec;19(1):1-110.1186/s12967-021-02751-3790588333632238
    Search in Google ScholarBack to article
  26. 26. Brudașcă I, Cucuianu M. Abnormal lipid metabolism in metabolic syndrome: an epigenetic perspective. R Rom Med Lab. 2016 Jun;24(2):153-6010.1515/rrlm-2016-0025
    Search in Google ScholarBack to article
  27. 27. Epingeac ME, Gaman MA, Diaconu CC, Gaman AM. Crosstalk between Oxidative Stress and Inflammation in Obesity. Rev. Chim. 2020;71:228-32
    Search in Google ScholarBack to article
  28. 28. Pouvreau C, Dayre A, Butkowski EG, De Jong B, Jelinek HF. Inflammation and oxidative stress markers in diabetes and hypertension. J Inflamm Res. 2018;11:61-6810.2147/JIR.S148911582284429497324
    Search in Google ScholarBack to article
  29. 29. Wang L, Ahn YJ, Asmis R. Sexual dimorphism in glutathione metabolism and glutathione-dependent responses. Redox Biology. 2020 Apr;31:101410:1-910.1016/j.redox.2019.101410721249131883838
    Search in Google ScholarBack to article
  30. 30. Williams CR, Mistry M, Cheriyan AM, Williams JM, Naraine MK, Ellis CL, et al. Zinc deficiency induces hypertension by promoting renal Na+ reabsorption. Am J Physiol Ren Physiol. 2019 Apr;316(4):F646-5310.1152/ajprenal.00487.2018648302830649891
    Search in Google ScholarBack to article
  31. 31. Choi S, Liu X, Pan Z. Zinc deficiency and cellular oxidative stress: prognostic implications in cardiovascular diseases. Acta Pharmacol Sin. 2018 Jul;39(7):1120-3210.1038/aps.2018.25628939629926844
    Search in Google ScholarBack to article
  32. 32. Pawluk H, Pawluk R, Robaczewska J, Kędziora-Kornatowska K, Kędziora J. Biomarkers of antioxidant status and lipid peroxidation in elderly patients with hypertension. Redox Report. 2017 Nov;22(6):542-610.1080/13510002.2017.1372072890062028873049
    Search in Google ScholarBack to article
  33. 33. Găman MA, Epîngeac ME, Diaconu CC, Găman AM. Evaluation of oxidative stress levels in obesity and diabetes by the free oxygen radical test and free oxygen radical defence assays and correlations with anthropo-metric and laboratory parameters. World J Diabetes. 2020 May;11(5):19310.4239/wjd.v11.i5.193724348432477455
    Search in Google ScholarBack to article
  34. 34. Casoinic F, Sampelean D, Buzoianu AD, Hancu N, Baston D. Serum levels of oxidative stress markers in patients with type 2 diabetes mellitus and non-alcoholic steatohepatitis. Rom J Intern Med. 2016 Dec;54(4):228-3610.1515/rjim-2016-003528002036
    Search in Google ScholarBack to article
  35. 35. Ahmad KA, Yuan Yuan D, Nawaz W, Ze H, Zhuo CX, Talal B, et al. Antioxidant therapy for management of oxidative stress induced hypertension. Free Radic Res. 2017 Apr;51(4):428-3810.1080/10715762.2017.132220528427291
    Search in Google ScholarBack to article
  36. 36. Keti DB, Muhtaroglu S. Reliability of Friedewald formula in patients with type 2 diabetes mellitus and its relation to lipid profile in diabetes regulation. Rev Romana Med Lab. 2021;29(2):179-187
    Search in Google ScholarBack to article
DOI: https://doi.org/10.2478/rrlm-2022-0025 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Journal RSS Feed
Language: English
Page range: 413 - 422
Submitted on: Mar 31, 2022
|
Accepted on: Aug 23, 2022
|
Published on: Oct 20, 2022
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
hypertension,
diabetes mellitus,
oxidative stress markers,
cardiovascular complications,
HPLC
Related subjects:
Life sciences,
Molecular biology,
Biochemistry,
Human biology,
Microbiology and virology

© 2022 Enikő Nemes-Nagy, Erzsébet Fogarasi, Mircea Dumitru Croitoru, Zoltán Preg, Sándor Pál, Kinga-Ilona Nyulas, Tünde Pál, Robert Gabriel Tripon, Mariana Cornelia Tilinca, Márta Germán-Salló, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 30 (2022): Issue 4 (October 2022)Next article